Novo Nordisk Invests $2 Billion to Increase Production
August 27 2015 - 2:12AM
Dow Jones News
By Dominic Chopping
Danish insulin maker Novo Nordisk A/S (NVO) said late Wednesday
it will invest $2 billion over the next five years in new
production facilities in the U.S. and Denmark to meet increasing
global demand for diabetes medicines.
The company estimates 700 new production and engineering jobs
will be created at the Clayton, North Carolina site, where it
already employs over 700. The new facilities will produce
ingredients for Novo Nordisk's current and furture range of
pharmaceuticals.
In Malov, Denmark, the new site will provide tableting and
packaging of oral products, with 100 new jobs created.
The final design and cost of the new facilities will be
presented in 2016 and are expected to be operational during
2020.
-Write to Dominic Chopping at dominic.chopping@wsj.com; Twitter:
@WSJNordics
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
(END) Dow Jones Newswires
August 27, 2015 01:57 ET (05:57 GMT)
Copyright (c) 2015 Dow Jones & Company, Inc.
Novo Nordisk (NYSE:NVO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Novo Nordisk (NYSE:NVO)
Historical Stock Chart
From Apr 2023 to Apr 2024
